Descubra el nuevo Chem-Impex: donde la innovación comienza con un vínculo.

Catalog Number:
38052
CAS Number:
151767-02-1
Hidrato de sodio de montelukast
Purity:
≥ 98 % (HPLC)
Documents
$73.71 /200 mg
Tamaño
Request Bulk Quote
Información del producto

Montelukast sodium hydrate is a potent leukotriene receptor antagonist widely utilized in the management of asthma and allergic rhinitis. This compound works by inhibiting the action of leukotrienes, which are inflammatory mediators that contribute to bronchoconstriction and mucus production. As a result, Montelukast sodium hydrate is effective in reducing airway inflammation and improving respiratory function, making it a valuable option for patients suffering from chronic respiratory conditions.

In addition to its primary applications in respiratory health, Montelukast sodium hydrate has shown promise in various research settings, including studies on exercise-induced bronchoconstriction and allergic responses. Its ability to provide relief from symptoms without the sedative effects commonly associated with other medications makes it a preferred choice among healthcare professionals. With its favorable safety profile and ease of administration, Montelukast sodium hydrate continues to be a critical component in the therapeutic arsenal against asthma and allergies.

Número CAS
151767-02-1
Fórmula molecular
C35H35ClNNaO3S · xH2O
Peso molecular
626.18
Número MDL
MFCD00931431
Rotación óptica
[a] D 20 = 95 - 105 ° (C=1 en MeOH)
Condiciones
Conservar entre 2 y 8 °C.
Información general
Número CAS
151767-02-1
Fórmula molecular
C35H35ClNNaO3S · xH2O
Peso molecular
626.18
Número MDL
MFCD00931431
Rotación óptica
[a] D 20 = 95 - 105 ° (C=1 en MeOH)
Condiciones
Conservar entre 2 y 8 °C.
Propiedades
¡Pronto habrá más información sobre la propiedad!
-
Seguridad y normativas
Materiales peligrosos
-
Antibiótico
-
Regulado por la DEA
No
Advertencias
-
Aplicaciones

Montelukast sodium hydrate is widely utilized in research focused on:

  • Asthma Management: This compound is primarily used as a medication to prevent asthma attacks by blocking leukotrienes, which are substances in the body that cause inflammation and bronchoconstriction. It is particularly beneficial for patients with exercise-induced bronchoconstriction.
  • Allergy Treatment: It is effective in alleviating symptoms of allergic rhinitis, such as sneezing and runny nose, making it a valuable option for individuals suffering from seasonal allergies.
  • Pediatric Applications: Montelukast sodium hydrate is safe for use in children, providing a non-steroidal option for managing asthma and allergies, which is crucial for parents looking for effective treatments without the side effects associated with steroids.
  • Chronic Obstructive Pulmonary Disease (COPD): Research has shown that this compound can be beneficial in managing symptoms of COPD, offering an alternative treatment avenue for patients with chronic respiratory issues.
  • Research in Inflammation: Beyond its clinical applications, montelukast sodium hydrate is also studied in laboratories for its potential effects on various inflammatory conditions, providing insights that could lead to new therapeutic strategies.

Citas